16 March 2017

PLOS NTD highlights crucial role for expert meetings in NTD product development programs

Pediatric Praziquantel Consortium shares its experience with organizing expert meetings

Drug research and development (R&D) programs for neglected tropical diseases (NTDs) are frequently organized in public-private partnerships (PPPs). Such partnerships integrate resources, technical facilities and knowledge of public and private partners into a collective action to develop and deliver safe and affordable treatments for NTDs.

By sharing experiences from the Consortium, the PLOS NTD Symposium Article highlights the crucial role of expert meetings in PPPs targeting NTDs. As depicted in the article, each phase of the R&D program poses its own challenges, from drug formulation to drug deployment. To address those challenges, the Pediatric Praziquantel Consortium integrates output from expert meetings tailored to the objectives of each phase of the R&D program. Expert meetings engage Consortium partners and a collection of experienced external actors who can contribute valuable situated knowledge or have a stake in the program's outcome.

In conclusion, these expert meetings have significantly contributed to the Consortium success thus far, and the Consortium will maintain this concept for our upcoming project phases. We believe that sharing this experience will be of great value for members of other NTD R&D programs.